Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: PreOperative Endocrine Therapy for Individualised Care With Abemaciclib [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating preoperative endocrine therapy with abemaciclib for individualized care in breast cancer is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer Female | Phase 3 | Status: ACTIVE_NOT_RECRUITING